Cleared Traditional

K926095 - REFRACTROL-SP
(FDA 510(k) Clearance)

K926095 · Medical Specialties, Inc. · Chemistry
Jan 1993
Decision
55d
Days
Class 1
Risk

K926095 is an FDA 510(k) clearance for the REFRACTROL-SP. This device is classified as a Single (specified) Analyte Controls (assayed And Unassayed) (Class I — General Controls, product code JJX).

Submitted by Medical Specialties, Inc. (South Plainfield, US). The FDA issued a Cleared decision on January 26, 1993, 55 days after receiving the submission on December 2, 1992.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1660.

Submission Details

510(k) Number K926095 FDA.gov
FDA Decision Cleared SESE
Date Received December 02, 1992
Decision Date January 26, 1993
Days to Decision 55 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code JJX — Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class I — General Controls
CFR Regulation 21 CFR 862.1660

Similar Devices — JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 492
Beta-CrossLaps CalCheck 5
K170678 · Roche Diagnostics · Apr 2017
Elecsys CYFRA 21-1 CalCheck 5
K162173 · Roche Diagnostics · Jan 2017
Multichem A1c
K162514 · Technopath Manufacturing · Oct 2016
Audit MicroControls Linearity DROP LQ Blood Glucose
K161874 · Aalto Scientific, Ltd. · Aug 2016
LIAISON EBV IgM Serum Control Set
K161522 · DiaSorin, Inc. · Jun 2016
LIAISON CMV IgM Serum Control Set
K161526 · DiaSorin, Inc. · Jun 2016